MARKET

ARCT

ARCT

Arcturus
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.74
+0.92
+9.37%
Closed 16:00 12/06 EST
OPEN
9.91
PREV CLOSE
9.82
HIGH
11.29
LOW
9.91
VOLUME
122.26K
TURNOVER
--
52 WEEK HIGH
15.50
52 WEEK LOW
4.110
MARKET CAP
115.12M
P/E (TTM)
-7.5896
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ARCT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 7 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

ARCT News

  • Rock star Growth Puts Arcturus Therapeutics Holdings (NASDAQ:ARCT) In A Position To Use Debt
  • Simply Wall St..11/11 11:56
  • Arcturus Therapeutics EPS misses by $0.09, misses on revenue
  • seekingalpha.11/08 02:55
  • Arcturus Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
  • GlobeNewswire.11/07 21:01
  • Arcturus Therapeutics Expands Platform with STARR Technology
  • GlobeNewswire.11/07 12:30

More

Industry

Biotechnology & Medical Research
+0.66%
Pharmaceuticals & Medical Research
+0.49%

Hot Stocks

Name
Price
%Change

About ARCT

Arcturus Therapeutics Ltd. is a ribonucleic acid (RNA) medicines company. The Company owns Lipid-enabled and Unlocked Nucleomonomer Agent modified RNA (LUNAR) lipid-mediated delivery and Unlocked Nucleomonomer Agent (UNA) technology, including UNA Oligomers. The Company’s diverse pipeline of RNA therapeutics includes programs pursuing rare diseases, Hepatitis B, non-alcoholic steatohepatitis (NASH), cystic fibrosis and vaccines. The Company’s versatile RNA therapeutics platforms can be applied toward multiple types of RNA medicines, including small interfering RNA, messenger RNA, replicon RNA, antisense RNA, microRNA and gene editing therapeutics. The Company's UNA technology can be used to target individual genes in the human genome, as well as viral genes, and other species for therapeutic purposes.
More

Webull offers Arcturus Therapeutics Ltd (ARCT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.